The Epstein-Barr Virus Glycoprotein gp150 Forms an Immune-Evasive Glycan Shield at the Surface of Infected Cells

Targeted Delivery of a Sialic Acid-Blocking Glycomimetic to Cancer Cells Inhibits Metastatic Spread

(2015) Christian Büll et al.   ACS Nano

The Immunology of Epstein-Barr Virus–Induced Disease

(2015) Graham S. Taylor et al.   Annual Review of Immunology

Biology of CD1- and MR1-Restricted T Cells

(2014) Mariolina Salio et al.   Annual Review of Immunology

Silencing the shutoff protein of Epstein-Barr virus in productively infected B cells points to (innate) targets for immune evasion

(2014) M. van Gent et al.   JOURNAL OF GENERAL VIROLOGY

A high-coverage shRNA screen identifies TMEM129 as an E3 ligase involved in ER-associated protein degradation

(2014) Michael L. van de Weijer et al.   Nature Communications

Cooperation between Epstein-Barr Virus Immune Evasion Proteins Spreads Protection from CD8+ T Cell Recognition across All Three Phases of the Lytic Cycle

(2014) Laura L. Quinn et al.   PLoS Pathogens

EBV BILF1 Evolved To Downregulate Cell Surface Display of a Wide Range of HLA Class I Molecules through Their Cytoplasmic Tail

(2013) B. D. Griffin et al.   JOURNAL OF IMMUNOLOGY

Targeting Aberrant Sialylation in Cancer Cells Using a Fluorinated Sialic Acid Analog Impairs Adhesion, Migration, and In Vivo Tumor Growth

(2013) C. Bull et al.   MOLECULAR CANCER THERAPEUTICS

The Secret Life of Viral Entry Glycoproteins: Moonlighting in Immune Evasion

(2013) Jonathan D. Cook et al.   PLoS Pathogens

Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome

(2012) Cory D Rillahan et al.   Nature Chemical Biology

Isolation of Reovirus T3D Mutants Capable of Infecting Human Tumor Cells Independent of Junction Adhesion Molecule-A

(2012) Diana J. M. van den Wollenberg et al.   PLoS One

Hiding Lipid Presentation: Viral Interference with CD1d-Restricted Invariant Natural Killer T (iNKT) Cell Activation

(2012) Daniëlle Horst et al.   Viruses-Basel

Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies

(2012) Barbara Kropff et al.   PLoS Pathogens

Herpes Simplex Virus 1 Glycoprotein B and US3 Collaborate To Inhibit CD1d Antigen Presentation and NKT Cell Function

(2011) P. Rao et al.   JOURNAL OF VIROLOGY

Antibody Evasion by a Gammaherpesvirus O-Glycan Shield

(2011) Bénédicte Machiels et al.   PLoS Pathogens

Viral evasion of T cell immunity: ancient mechanisms offering new applications

(2010) Daniëlle Horst et al.   CURRENT OPINION IN IMMUNOLOGY

Sialylation of 3-Methylcholanthrene-Induced Fibrosarcoma Determines Antitumor Immune Responses during Immunoediting

(2010) M. Cohen et al.   JOURNAL OF IMMUNOLOGY

The Epstein-Barr Virus-Encoded BILF1 Protein Modulates Immune Recognition of Endogenously Processed Antigen by Targeting Major Histocompatibility Complex Class I Molecules Trafficking on both the Exocytic and Endocytic Pathways

(2010) J. Zuo et al.   JOURNAL OF VIROLOGY

Identification ofN-glycans from Ebola virus glycoproteins by matrix-assisted laser desorption/ionisation time-of-flight and negative ion electrospray tandem mass spectrometry

(2010) Gayle Ritchie et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

Steric Shielding of Surface Epitopes and Impaired Immune Recognition Induced by the Ebola Virus Glycoprotein

(2010) Joseph R. Francica et al.   PLoS Pathogens

The Epstein-Barr Virus G-Protein-Coupled Receptor Contributes to Immune Evasion by Targeting MHC Class I Molecules for Degradation

(2009) Jianmin Zuo et al.   PLoS Pathogens